Merck Gains Oxytrol OTC Rights
WHITEHOUSE STATION, N.J. (AP) — Merck & Co. said it received approval to market the overactive bladder patch Oxytrol over the counter.
Oxytrol has been on the market since 2003 as a treatment for overactive bladder in women. Merck gained the right to sell the over-the-counter version from Actavis Inc., which makes the original version.
Date: January 25, 2013
Source: Associated Press